Rate Of Return$ABBISKO-B(02256.HK)
As a representative of innovative technology, innovative drug sector reflects the development of China's innovation to some extent. Among them, cancer treatment and prevention have the greatest potential, due to the use of food additives, hormones, and unhealthy eating habits developed in recent decades. The market space is enormous in the coming decades. Hepalink is undervalued and has huge potential.$ABBISKO-B(02256.HK)
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
